We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Doctors may contact the FDA by phone, fax or email to seek approval for emergency use of an investigative drug, but a phone call is best after hours, the agency says, in a newly updated policy manual. Read More
Biocon said it plans to re-submit applications for European approval of two cancer-treatment biosimilars as soon as it corrects serious GMP deficiencies found at a Bangalore manufacturing plant. The company said it intends to fix the problems by Sept. 30. Read More
South Carolina has joined the long list of states taking legal action against Purdue Pharma, maker of OxyContin (oxycodone), the company’s extended-release prescription opioid painkiller. Read More
An Ohio advocacy group filed a complaint with the state’s Election Commission claiming drugmakers covertly funded efforts against a drug pricing ballot initiative. Read More
The state of Maryland defended its law against generic drug price gouging in court, moving to dismiss a complaint brought by the industry’s trade group, the Association for Accessible Medicines. Read More